The reduction of Pi4ka inhibits myeloid and erythroid cell differentiation in vitro and promotes anemia in vivo through a mechanism involving the deregulation of AKT, MAPK, and JAK-STAT signaling pathways (Ziyad et al., 2018). The gene discussed is PI4KA; the disease is anemia.